SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

Delhi High Court Temporarily Bars NPPA Action Against AstraZeneca

The court restrained the National Pharmaceutical Pricing Authority from taking coercive action to recover more than Rs 151 crore in an alleged drug overcharging case.

ASTRAZEN

Story updates

04:13:03 AM UTC
SquawkNews
Indu Bhan New Delhi: The Delhi High Court has restrained the National Pharmaceutical Pricing Authority (NPPA) from taking any coercive action against AstraZeneca Pharma India to recover over 151 crore in an alleged drug overcharging case until January 11, the next date of hearing.AstraZeneca Pharma…
04:13:40 AM UTC
SquawkNews
AstraZeneca Gets HC Relief in Pricing Case

Indu Bhan New Delhi: The Delhi High Court has temporarily restrained the National Pharmaceutical Pricing Authority (NPPA) from taking any coercive action against AstraZeneca Pharma India for recovering more than Rs 151 crore in the alleged drug overcharging case.The court order will be in effect ti…

Related stories